ReviewThe opposing effects of n−3 and n−6 fatty acids
Introduction
Polyunsaturated fatty acids (PUFAs) are fatty acids containing two or more double bonds. PUFAs are classified as n−3 and n−6 on the basis of the location of the last double bond relative to the terminal methyl end of the molecule. Both types of fatty acids are obtained through diet. In westernized diets linoleic acid (LA), (n−6) is the primary PUFA followed by α-linolenic acid (n−3). Because these two fatty acids cannot be synthesized in mammals, they are defined as essential fatty acids. Major sources of n−6 fatty acids are vegetable oils such as corn, safflower and soybean oil, whereas n−3 fatty acid sources are fish, such as salmon, trout and tuna [1].
Once consumed, these fatty acids are further metabolized within mammalian cells (Fig. 1). LA (18:2 n−6) is converted to γ-linolenic acid (18:3 n−6), and dihomo-γ-linolenic acid (20:3 n−6) to form the key intermediate arachidonic acid (AA) (20:4 n−6) by various desaturase- and elongase-enzymes. AA is further metabolized to docosapentaenoic acid (22:5 n−6) or eicosanoids.
The n−3 fatty acid α-linolenic acid (18:3 n−3) is converted to stearidonic acid (18:4 n−3) and eicosatetraenoic acid (20:4 n−3) to form eicosapentaenoic acid (EPA) (20:5 n−3) using the same series of enzymes as those used to synthesize AA. EPA is further metabolized to docosahexaenoic acid (22:6 n−3) or eicosanoids.
Since conversion of n−3 and n−6 fatty acids share the same series of enzymes (Fig. 1), a competition exists between the n−3 and n−6 fatty acid families for metabolism with an excess of one causing a significant decrease in the conversion of the other.
Section snippets
Biosynthesis of eicosanoids and other autacoids
Eicosanoids are key products synthesized from the 20-carbon polyunsaturated fatty acids, AA (n−6) and EPA (n−3). Because membranes contain mainly AA compared to EPA, AA is the predominant precursor for eicosanoid biosynthesis. The carboxylgroups of n−6/n−3 PUFAs are esterified with the hydroxyl groups of the glycerol backbone of phospholipids or glycerides. Thus, n−6/n−3 PUFAs are stored in esterified form in phospholipids of the cytosolic leaflet of cell and organelle membranes or in lipid
Opposing effects of n−3- and n−6 fatty acid-derived eicosanoids
The difference between n−3 and n−6 fatty acid-derived eicosanoids is that most of the mediators formed from EPA and DHA are anti-inflammatory, whereas those formed from AA are pro-inflammatory or show other disease-propagating effects (Table 1) [9], [10].
Prostaglandins PGI2 and PGE2, generated from AA, have pro-arrhythmic effects, whereas the EPA-derived prostaglandins PGI3 and PGE3 are anti-arrhythmic [11]. Concerning inflammatory modulation PGE2 has both pro- and anti-inflammatory effects. PGE
Effects of n−3 and n−6 fatty acids on G protein-coupled receptors
Although evidence for direct PUFA–protein interaction is rare, there are a few important studies showing direct interactions between PUFAs and G protein-coupled receptors (GPCRs). Rhodopsin is a GPCR responsible for sensing light in the retina. Functional studies of rod outer segment membranes of the retina isolated from rats fed n−3 fatty acid deficient diets showed a dramatic decrease in G protein-coupled receptor signalling of the rhodopsin photocycle [34], [35]. Nuclear magnetic resonance
n−3 and n−6 fatty acid effects on membrane fluidity
Fatty acids as components of biological membranes strongly influence their fluidity. With an increase in unsaturated fatty acids membrane fluidity increases. The reason for this is that PUFA acyl chains are extremely flexible and can rapidly change conformational states [41]. The acyl chain flexibility differs substantially between n−3 and n−6 fatty acids and the number of double bonds significantly alters membrane fluidity [42], [43]. Thus, the n−3 and n−6 fatty composition of biological
Effects of n−3 and n−6 fatty acids on gene expression
Many of the effects of n−3 and n−6 fatty acids are exerted through altered gene expression (Fig. 3). Nuclear receptors (NR) are a family of ligand-activated transcription factors that directly and indirectly control several genes of lipid metabolism and inflammatory signalling. The structural organization of nuclear receptor family members is similar despite wide variation in ligand specificity. With few exceptions, these proteins contain an NH2-terminal region that harbours a
Conclusion
n−6 and n−3 fatty acids are stored in phospholipids of cell and organelle membranes and in glycerides and phospholipids of lipid bodies. These fatty acids are released from phospholipids by PLA2 and are further metabolised to eicosanoids and other autacoids. AA (n−6)-derived eicosanoids are mostly pro-active, whereas EPA (n−3)-derived eicosanoids are inhibitory. The n−6/n−3 content of cell and organelle membranes and lipid membrane microdomains strongly influence membrane function and numerous
References (92)
- et al.
The cellular biology of eosinophil eicosanoid formation and function
J Allergy Clin Immunol
(2002) - et al.
Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking
J Biol Chem
(2004) - et al.
Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins
Meth Enzymol
(2007) - et al.
Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes
Prostaglandins
(1997) - et al.
Endogenous anti-inflammatory mediators from arachidonate in human neutrophils
Biochem Biophys Res Commun
(2002) - et al.
The conversion of dietary eicosapentaenoic acid to prostanoids and leukotrienes in man
Prog Lipid Res
(1986) Polyunsaturated fatty acids and inflammation
Prostag Leukot Essent Fatty Acids
(2006)- et al.
Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions
J Invest Dermatol
(1989) - et al.
Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation
J Biol Chem
(2003) - et al.
Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression
J Biol Chem
(2003)